| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 55.6% | 84/151 |
| Female | 44.4% | 67/151 |
| Indifferent | 0% | 0/151 |
| Unknown | 0% | 0/151 |
| General | ||
| 10.9% | 15/138 | |
| 16.2% | 23/142 | |
| 7.3% | 10/137 | |
| 42.9% | 63/147 | |
| 21.6% | 30/139 | |
| 12.8% | 18/141 | |
| 64.1% | 91/142 | |
| 49.3% | 70/142 | |
| 45.5% | 66/145 | |
| 77.9% | 60/77 | |
| Neurology | ||
| 47.3% | 71/150 | |
| 73.3% | 110/150 | |
| 17.3% | 26/150 | |
| Facial abnormalities | ||
| 48.7% | 73/150 | |
| 56% | 84/150 | |
| 70.7% | 106/150 | |
| 87.3% | 131/150 | |
| Visual and hearing impairments | ||
| 46.7% | 70/150 | |
| 52.7% | 79/150 | |
| Heart | ||
| 26% | 39/150 | |
| Pulmonary | ||
| 4.5% | 4/88 | |
| Gastrointestinal | ||
| 51.3% | 77/150 | |
| Urogenital | ||
| 29.3% | 44/150 | |
| Skeleton | ||
| 83.3% | 125/150 | |
| Skin / Hair / Nails | ||
| 36.7% | 55/150 | |
| Endocrine / Immunological / Metabolic | ||
| 12.7% | 19/150 | |
| 18.7% | 28/150 | |
| 16% | 24/150 | |
| Neoplasia | ||
| 0.7% | 1/150 | |
| Inheritance | ||
| 75.9% | 41/54 | |
ANKRD11